Reproterol

DB12846InvestigationalSmall molecule

Reproterol is a short-acting β2 adrenoreceptor agonist used to treat various types of asthma including allergic asthma, non-allergic asthma, and exercise-induced asthma. A type of medication used in inhalers to treat shortness of breath associated with asthma.

Chemical structure of Reproterol
Mechanism
Curator reviewed · 1 reference
Formula / weight
C18H23N5O5 · 389.412 g/mol (avg)
Code names
D-1959

Resolves to

Compound
UNII11941YC6RNCAS54063-54-6ChEMBLCHEMBL1095607ChEBI135612PubChem25654
Clinical / RWD
RxNorm35373ATCR03AC15ATCR03AK05ATCR03CC14
Structure
InChIKeyWVLAAKXASPCBGT-UHFFFAOYSA-NSMILESCN1C2=C(N(CCCNCC(O)C3=CC(O)=CC(O)=C3)C=N2)C(=O)N(C)C1=O
Targets
P07550ADRB2

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
674Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
8ContraindicationsEach with its own population and attribute set
Sign in
7Marketed productsAcross 2 countries and 1 labeller
Sign in
3ATC codesIncluding every combination product, plus 28 drug categories
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Reproterol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In